Novo Nordisk Introduces New Insulin Device to U.S. Market

| Jul 26, 2014

Novo Nordisk has introduced the Levemir® FlexTouch® prefilled insulin delivery device to the U.S. market. The device, filled with insulin detemir [rDNA origin], the first of its kind that does not use a pushbutton extension. In a conventional insulin delivery device, a pushbutton extends out from the device. If the called-for dose is large, an extension may cause problems for the user.

In the FlexTouch, Novo Nordisk says a simple low injection-force button serves to deliver whatever necessary dose without involving any extra effort by the user. The prefilled device contains 300 units of insulin detemir, which it can dose in 1-unit increments from 1 to 80 units.

FlexTouch is compatible with both NovoFine® and the latest NovoTwist® needles. An audible and tactile click confirms proper attachment of the needle to the device. Novo Nordisk advises that needles are sold separately and may require a prescription in some states.

The FDA approved the device last November. It has been approved for sale in Europe since mid-2011 and is also sold in Canada, Denmark, Japan, and the United Kingdom.

According to Novo Nordisk, Levemir FlexTouch is available on more than 96 percent of Commercial and Medicare Part D plans nationwide, including exclusive Tier 1 status on UnitedHealthcare and preferred status on Coventry. For more information on Novo Nordisk products, visit

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes Health, Diabetes Health Magazine, diabetes medicine, flextouch, Insulin, insuline device, Levemir, Novo Nordisk, prefilled insulin, Type 1, Type 1 Diabetes, Type 2, type 2 diabetes

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.